Marimed (MRMD) Other financing activities (2013 - 2023)

Marimed (MRMD) has 9 years of Other financing activities data on file, last reported at $74000.0 in Q3 2023.

• On a quarterly basis, Other financing activities changed N/A year-over-year to $74000.0 in Q3 2023; TTM through Dec 2024 was $74000.0, a 32.11% decrease from a year earlier, with the FY2023 full-year figure at $109000.0, up 990.0% from the prior year.
• Other financing activities for Q3 2023 stood at $74000.0, up from $35000.0 in the prior quarter.
• Over the last five years, Other financing activities for MRMD reached as high as $586642.0 in Q2 2019 and fell as low as -$514942.0 in Q4 2019.
• Historically, Other financing activities has averaged $22590.9 across 4 years, with a median of $10000.0 in 2019.
• On a YoY basis, Other financing activities climbed as much as 7094.53% in 2019 and fell as far as 397.46% in 2019.
• Year by year, Other financing activities stood at -$514942.0 in 2019, then soared by 89.51% to -$54000.0 in 2021, then soared by 105.56% to $3000.0 in 2022, then surged by 2366.67% to $74000.0 in 2023.
• Per Business Quant data, the three most recent Other financing activities figures were $74000.0 in Q3 2023, $35000.0 in Q2 2023, and $3000.0 in Q1 2022.